Artivion, Inc. (AORT)
Healthcare • Medical Devices
StockNYSEUnited StatesUS2289031005
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Artivion, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:03. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 11 Feb 2027 16:00 | 0.09 | — | — | Upcoming |
| 05 Nov 2026 16:00 | 0.07 | 0.08 | +21.2% | Beat |
| 06 Aug 2026 16:00 | 0.10 | 0.13 | +34.5% | Beat |
| 07 May 2026 16:00 | 0.12 | 0.08 | -35.1% | Miss |
| 12 Feb 2026 16:00 | 0.18 | 0.17 | -3.4% | Miss |
| 06 Nov 2025 16:00 | 0.15 | 0.16 | +5.3% | Beat |
| 07 Aug 2025 16:00 | 0.13 | 0.24 | +92.0% | Beat |
| 05 May 2025 16:00 | 0.05 | 0.06 | +33.3% | Beat |
| 24 Feb 2025 16:00 | 0.04 | — | -100.0% | — |
| 07 Nov 2024 16:00 | 0.01 | 0.12 | +1,100.0% | Beat |
| 08 Aug 2024 16:00 | 0.03 | 0.07 | +162.5% | Beat |
| 06 May 2024 16:00 | 0.02 | 0.06 | +157.2% | Beat |
| 15 Feb 2024 16:00 | — | 0.11 | — | — |
| 02 Nov 2023 16:00 | 0.03 | 0.02 | -33.3% | Miss |
| 03 Aug 2023 16:00 | 0.02 | 0.06 | +200.0% | Beat |
| 04 May 2023 16:00 | -0.02 | 0.02 | +188.9% | Beat |
| 16 Feb 2023 16:00 | -0.02 | 0.10 | +671.4% | Beat |
| 03 Nov 2022 16:00 | -0.04 | -0.05 | -11.1% | Miss |
| 04 Aug 2022 16:00 | 0.03 | -0.03 | -190.0% | Miss |
| 05 May 2022 16:00 | -0.01 | 0.03 | +549.8% | Beat |
| 17 Feb 2022 16:00 | 0.04 | — | -100.0% | — |
| 04 Nov 2021 16:00 | 0.03 | -0.03 | -200.0% | Miss |
| 29 Jul 2021 16:00 | 0.07 | 0.12 | +84.6% | Beat |
| 29 Apr 2021 16:00 | 0.10 | 0.03 | -70.0% | Miss |
| 11 Feb 2021 16:00 | 0.03 | 0.20 | +566.7% | Beat |
| 04 Nov 2020 16:00 | -0.04 | 0.13 | +388.9% | Beat |
| 30 Jul 2020 16:00 | -0.14 | -0.02 | +86.1% | Beat |
| 30 Apr 2020 16:00 | 0.02 | -0.08 | -508.2% | Miss |
| 13 Feb 2020 16:00 | 0.08 | 0.10 | +29.7% | Beat |
| 30 Oct 2019 16:00 | 0.06 | 0.06 | +7.0% | Beat |
| 30 Jul 2019 16:00 | 0.07 | 0.11 | +51.7% | Beat |
| 30 Apr 2019 16:00 | 0.04 | 0.04 | +0.5% | In line |
| 13 Feb 2019 19:00 | 0.11 | 0.05 | -55.9% | Miss |
| 31 Oct 2018 17:00 | 0.07 | 0.08 | +7.8% | Beat |
| 06 Aug 2018 16:00 | 0.07 | 0.10 | +36.4% | Beat |
| 02 May 2018 17:00 | 0.03 | 0.02 | -33.3% | Miss |
| 07 Mar 2018 18:00 | 0.11 | 0.11 | 0.0% | In line |
| 30 Oct 2017 17:00 | 0.08 | 0.08 | -4.0% | Miss |
| 24 Jul 2017 17:00 | 0.10 | 0.12 | +20.0% | Beat |
| 26 Apr 2017 17:00 | 0.04 | 0.09 | +125.0% | Beat |
| 15 Feb 2017 17:00 | 0.09 | 0.12 | +41.2% | Beat |
| 26 Oct 2016 17:00 | 0.05 | 0.13 | +173.7% | Beat |
| 25 Jul 2016 17:00 | 0.07 | 0.13 | +92.6% | Beat |
| 27 Apr 2016 17:00 | 0.04 | 0.10 | +185.7% | Beat |
| 15 Feb 2016 17:00 | 0.05 | 0.13 | +160.0% | Beat |
| 27 Oct 2015 06:00 | 0.02 | 0.10 | +566.7% | Beat |
| 28 Jul 2015 08:00 | — | 0.03 | — | — |
| 28 Apr 2015 08:00 | 0.01 | -0.01 | -200.0% | Miss |
| 17 Feb 2015 06:00 | 0.05 | 0.04 | -14.3% | Miss |
| 28 Oct 2014 08:00 | 0.05 | 0.08 | +71.4% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 441.3M | +13.6% | 9.8M | 2.2% | 0.21 | +165.6% | 839K |
| 2024 | 388.5M | +9.8% | -13.4M | -3.4% | -0.32 | +57.3% | 11M |
| 2023 | 354M | +12.8% | -30.7M | -8.7% | -0.75 | -56.3% | 9.1M |
| 2022 | 313.8M | — | -19.2M | -6.1% | -0.48 | — | -15.9M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 20.06 | 20.77 | 19.20 | 19.39 | -3.53% | 698,757 | |
| 11 Nov 2026 | 20.25 | 20.73 | 19.82 | 20.10 | -1.81% | 646,200 | |
| 10 Nov 2026 | 20.43 | 20.69 | 19.21 | 20.47 | -0.82% | 997,900 | |
| 09 Nov 2026 | 20.32 | 21.06 | 19.33 | 20.64 | +2.13% | 1,662,800 | |
| 06 Nov 2026 | 22.19 | 23.01 | 19.74 | 20.21 | -20.21% | 3,247,000 | |
| 05 Nov 2026 | 26.93 | 27.00 | 24.69 | 25.33 | -4.23% | 1,127,700 | |
| 04 Nov 2026 | 24.45 | 26.69 | 24.45 | 26.45 | +11.56% | 1,086,400 | |
| 03 Nov 2026 | 23.56 | 23.94 | 23.22 | 23.71 | +0.55% | 645,700 | |
| 02 Nov 2026 | 22.87 | 23.93 | 22.82 | 23.58 | +4.43% | 626,200 | |
| 30 Oct 2026 | 23.62 | 23.62 | 21.85 | 22.58 | -3.67% | 627,400 | |
| 1,254 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Artivion, Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 10 Nov 2026 18:36
- AORT Q3 2026 deep dive: stent graft growth and NEXUS launch preparations shape outlook (opens in a new tab) StockStory · 10 Nov 2026 13:17
- Artivion (AORT) Stock Looks About Right Following Nexus Launch Preparations (opens in a new tab) Simply Wall St. · 10 Nov 2026 06:11
- Is Artivion (AORT) Undervalued Following Mixed Earnings And A Return To Losses? (opens in a new tab) Simply Wall St. · 07 Nov 2026 17:12
- Artivion Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 07 Nov 2026 00:14
- Canaccord Genuity Maintains Buy on Artivion, Lowers Price Target to $30 (opens in a new tab) Benzinga · 06 Nov 2026 15:48
- Artivion, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 06 Nov 2026 13:30
- Citizens Maintains Market Outperform on Artivion, Lowers Price Target to $42 (opens in a new tab) Benzinga · 06 Nov 2026 11:12
- Artivion Inc (AORT) (Q3 2026) Earnings Call Highlights: Stent Graft Momentum and Nexus Launch ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 09:20
- What Artivion (AORT)'s Revenue Growth And Loss Mean For Shareholders (opens in a new tab) Simply Wall St. · 06 Nov 2026 08:12
- Artivion (AORT) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 06 Nov 2026 06:46
- ARTIVION INC (NYSE:AORT) Q3 EPS Beat Meets Inline Revenue (opens in a new tab) ChartMill · 05 Nov 2026 23:11
- Artivion (AORT) Lags Q3 Earnings Estimates (opens in a new tab) Zacks · 05 Nov 2026 21:45
- Artivion’s (NYSE:AORT) Q3 2026 sales beat estimates (opens in a new tab) StockStory · 05 Nov 2026 21:36
- Artivion: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 05 Nov 2026 21:16
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 20.10 USD
- Market cap
- 979.7M
- 5-year average yield
- 0.74%
- Last dividend
- 0.0300 USD · 09 Dec 2015
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Devices
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 09 Dec 2015 | 0.0300 USD |
| 09 Sep 2015 | 0.0300 USD |
| 10 Jun 2015 | 0.0300 USD |
| 11 Mar 2015 | 0.0300 USD |
| 8 older dividends: create a free account to see them | |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 20.1 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 3.3 / 25 |
|
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 0.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 0.4 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 10.0 / 10 |
|
- Heavy debt: net debt is 5.7× EBITDA
- Thin interest cover: operating profit is only 1.0× the interest
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (forward) | 38.65× | Weak | 14.16× |
| Price / book | 2.2× | Fair | 3.5× |
| Price / sales | 2.04× | Fair | 3.33× |
| EV / EBITDA | 21.37× | Weak | 11.19× |
| Free cash flow yield | -4.5% | Weak | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 63.3% | Good | 54.9% |
| Operating margin | 7.6% | Weak | 5.8% |
| Net margin | -3.7% | Weak | 1.2% |
| Return on equity | -4% | Weak | 4.4% |
| Return on assets | 2.4% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 12% | Good | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.91× | Fair | 0.4× |
| Net debt / EBITDA | 5.72× | Weak | 1.46× |
| Interest cover | 1.01× | Weak | 2.17× |
| Current ratio | 4.42× | Good | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 0% | Weak | 0% |
| Dividend growth / year | 4.9% | Fair | 6.5% |
| Years of rising dividends | 2 | Weak | 1.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow AORT and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.